119 related articles for article (PubMed ID: 15560113)
21. Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells.
Calnek DS; Mazzella L; Roser S; Roman J; Hart CM
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):52-7. PubMed ID: 12524224
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway.
Napimoga MH; Vieira SM; Dal-Secco D; Freitas A; Souto FO; Mestriner FL; Alves-Filho JC; Grespan R; Kawai T; Ferreira SH; Cunha FQ
J Immunol; 2008 Jan; 180(1):609-17. PubMed ID: 18097063
[TBL] [Abstract][Full Text] [Related]
23. 15-Deoxy-Δ12,14-prostaglandin J2 induces PPARγ- and p53-independent apoptosis in rabbit synovial cells.
Sakaba Y; Awata H; Morisugi T; Kawakami T; Sakudo A; Tanaka Y
Prostaglandins Other Lipid Mediat; 2014 Jun; 109-111():1-13. PubMed ID: 24680891
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells.
Kim EH; Na HK; Surh YJ
Ann N Y Acad Sci; 2006 Dec; 1090():375-84. PubMed ID: 17384282
[TBL] [Abstract][Full Text] [Related]
25. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
Phulwani NK; Feinstein DL; Gavrilyuk V; Akar C; Kielian T
J Neurochem; 2006 Dec; 99(5):1389-1402. PubMed ID: 17074064
[TBL] [Abstract][Full Text] [Related]
26. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
Ray DM; Akbiyik F; Phipps RP
J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
[TBL] [Abstract][Full Text] [Related]
27. 15-deoxy-Delta12,14-prostaglandin J2-induced down-regulation of endothelial nitric oxide synthase in association with HSP70 induction.
Hwang J; Lee HI; Chang YS; Lee SJ; Kim KP; Park SI
Biochem Biophys Res Commun; 2007 May; 357(1):206-11. PubMed ID: 17418102
[TBL] [Abstract][Full Text] [Related]
28. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
30. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits the expression of granulocyte-macrophage colony-stimulating factor in endothelial cells stimulated with lipopolysaccharide.
Imaizumi T; Kumagai M; Hatakeyama M; Tamo W; Yamashita K; Tanji K; Yoshida H; Satoh K
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):293-9. PubMed ID: 14518569
[TBL] [Abstract][Full Text] [Related]
31. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells.
Srinivasan S; Hatley ME; Bolick DT; Palmer LA; Edelstein D; Brownlee M; Hedrick CC
Diabetologia; 2004 Oct; 47(10):1727-34. PubMed ID: 15490108
[TBL] [Abstract][Full Text] [Related]
32. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
Coyle AT; O'Keeffe MB; Kinsella BT
FEBS J; 2005 Sep; 272(18):4754-73. PubMed ID: 16156795
[TBL] [Abstract][Full Text] [Related]
33. 15-Deoxy-Δ12,14-Prostaglandin J
Urban I; Turinsky M; Gehrmann S; Morgenstern J; Brune M; Milewski MR; Wagner AH; Rumig C; Fleming T; Leuschner F; Gleissner CA; Hecker M
Circ Res; 2019 Jul; 125(3):282-294. PubMed ID: 31213138
[TBL] [Abstract][Full Text] [Related]
34. 15-deoxy-Delta12, 14-prostaglandin J2 activates the expression of p15INK4b gene, a cyclin-dependent kinase inhibitor.
Matsuzaki Y; Koyama M; Hitomi T; Takaoka Y; Kawanaka M; Sakai T
Int J Oncol; 2005 Aug; 27(2):497-503. PubMed ID: 16010433
[TBL] [Abstract][Full Text] [Related]
35. Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation.
Kobayashi Y; Ueki S; Mahemuti G; Chiba T; Oyamada H; Saito N; Kanda A; Kayaba H; Chihara J
J Immunol; 2005 Nov; 175(9):5744-50. PubMed ID: 16237065
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression.
Maggi LB; Sadeghi H; Weigand C; Scarim AL; Heitmeier MR; Corbett JA
Diabetes; 2000 Mar; 49(3):346-55. PubMed ID: 10868955
[TBL] [Abstract][Full Text] [Related]
37. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions.
Bernardo A; Levi G; Minghetti L
Eur J Neurosci; 2000 Jul; 12(7):2215-23. PubMed ID: 10947800
[TBL] [Abstract][Full Text] [Related]
38. PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease.
Marx N; Bourcier T; Sukhova GK; Libby P; Plutzky J
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):546-51. PubMed ID: 10073956
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta(12,14)-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway.
Seo SK; Seo DI; Park WS; Jung WK; Lee DS; Park SG; Choi JS; Kang MS; Choi YH; Choi I; Yu BC; Choi IW
Life Sci; 2014 Sep; 112(1-2):82-9. PubMed ID: 25072357
[TBL] [Abstract][Full Text] [Related]
40. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoter.
Engdahl R; Monroy MA; Daly JM
Biochem Biophys Res Commun; 2007 Jul; 359(1):88-93. PubMed ID: 17532302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
